<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="364808">
  <stage>Registered</stage>
  <submitdate>21/08/2013</submitdate>
  <approvaldate>5/09/2013</approvaldate>
  <actrnumber>ACTRN12613000990729</actrnumber>
  <trial_identification>
    <studytitle>Impact of luteal progesterone therapy on endometrial polyps accidentally discovered during routine infertility evaluation: randomized trial. </studytitle>
    <scientifictitle>women with detected endometrial polyps during routine infertility evaluation are randomized to receive luteal phase support by oral dydrogesterone or placebo to find out the impact on pregnancy rate and post-menstrual polyp persistence and size.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>endometrial polyps in infertility</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Fertility including in vitro fertilisation</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>luteal phase support by dydrogesterone oral tablets 30  mg/day for 10 days starting 2 days after sonographically detected ovulation. cases were appointed postmenstrually to reevaluate the endometrium and make sure that they received their treatment correctly. </interventions>
    <comparator>microcellulose placebo tablets.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>chemical pregnancy rate by serum beta hCG, and clinical pregnancy rate by detecting gestational sac with ultrasound.</outcome>
      <timepoint>Beta hCG was assayed 2 days after the date of missed period and ultrasonography was done one week later.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>persistence of polyps as seen by transvaginal sonography.</outcome>
      <timepoint>5 days from onset of menstrual bleeding.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Presence of endometrial polyp in an asymptomatic regularly menstruating woman ,evaluated for infertility for one year or more, and partner normal semen.</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>35</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>other causes of infertility, irregular or abnormal menstrual periods</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>sealed envelops</concealment>
    <sequence>computer generated tables</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>Sample-size was calculated using Chi-square test for independent samples with the occurrence of pregnancy as the primary outcome. For an a-error of 0.05, and a power of 80% the calculated size of each group was 50 cases. </statisticalmethods>
    <masking1>True</masking1>
    <masking2>False</masking2>
    <masking3>True</masking3>
    <masking4>False</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/06/2012</anticipatedstartdate>
    <actualstartdate>9/06/2012</actualstartdate>
    <anticipatedenddate>1/12/2013</anticipatedenddate>
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Egypt</country>
      <state>Alexandria</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Mervat sheikhelarab Elsedeek Omran. Professor of obstetrics and gynecology, Faculty of medicine, alexandria university.</primarysponsorname>
    <primarysponsoraddress>649 Elhoreya road Janaklis, Alexandria Egypt.
03312</primarysponsoraddress>
    <primarysponsorcountry>Egypt</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>none</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Asymptomatic women with endometrial polyps accidentally discovered during trans-vaginal sonography done for routine infertility evaluation were either given luteal dydrogesterone for endometrial support or placebo and followed up for occurrence of pregnancy and persistence of polyp after period if no pregnancy occurred.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Alexandria Faculty of Medicine institutional review board</ethicname>
      <ethicaddress>Alexandria faculty of medicine, Azarita, Alexandria, Egypt.
Post code: 03312</ethicaddress>
      <ethicapprovaldate>20/05/2012</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Egypt</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Mervat Sheikhelarab Elsedeek Omran.Professor of obstetrics and gynecology, Faculty of medicine, alexandria university.</name>
      <address>649 Elhoreya road, Janaklis, Alexandria.
03312</address>
      <phone>+203 5759915</phone>
      <fax />
      <email>mervatsheikhelarab@yahoo.com</email>
      <country>Egypt</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Mervat Sheikhelarab Elsedeek Omran.Professor of obstetrics and gynecology, Faculty of medicine, alexandria university.</name>
      <address>649 Elhoreya road, Janaklis, Alexandria.
03312</address>
      <phone>+203 5759915</phone>
      <fax />
      <email>mervatsheikhelarab@yahoo.com</email>
      <country>Egypt</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Mervat Sheikhelarab Elsedeek Omran.Professor of obstetrics and gynecology, Faculty of medicine, alexandria university.</name>
      <address>649 Elhoreya road, Janaklis, Alexandria.
03312</address>
      <phone>+203 5759915</phone>
      <fax />
      <email>mervatsheikhelarab@yahoo.com</email>
      <country>Egypt</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Mervat Sheikhelarab Elsedeek Omran</name>
      <address>649 Elhoreya road, Janaklis, Alexandria</address>
      <phone>+203 5759915</phone>
      <fax />
      <email>mervatsheikhelarab@yahoo.com</email>
      <country>Egypt</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>